Pre-diagnostic predictors of mortality in patients with heart failure: The multi-ethnic study of atherosclerosis

Mahsima Shabani1, Mohammad R Ostovaneh1,2, Xiaoyang Ma3

  • 1Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD, United States.

Insights

Cumulative exposure to risk factors before heart failure (HF) diagnosis, including cholesterol and glucose, improves prediction of cardiovascular mortality. This cumulative exposure offers greater accuracy than latest measures for HF mortality prediction.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Cardiovascular (CV) mortality prediction in heart failure (HF) often relies on factors measured after diagnosis.
  • The impact of long-term exposure to these predictors before HF diagnosis remains unclear.

Purpose of the Study:

  • To identify predictors of CV mortality in HF patients.
  • To assess the role of cumulative exposure to risk factors prior to HF development.

Main Methods:

  • Utilized data from the Multi-Ethnic Study of Atherosclerosis (MESA) cohort with incident HF.
  • Employed stepwise Akaike Information Criterion to select CV mortality predictors from clinical, biochemical, and imaging markers.
  • Estimated cumulative exposure to predictors using B-spline-corrected curves and evaluated prognostic performance with competing risk regression.

Main Results:

  • The study included 375 participants with new HF events (mean age 74).
  • Key predictors of CV mortality included age, cardiac arrest, myocardial infarction, diabetes, QRS duration, HDL, cumulative cholesterol and glucose exposure, NT-proBNP, left ventricular mass, and statin use.
  • Cumulative prior exposure yielded a higher AUC (0.79) compared to latest exposure (0.72).

Conclusions:

  • Age, diabetes, prior lipid profile, NT-proBNP, LV mass, and QRS duration predict CV mortality in HF patients.
  • Cumulative exposure to cholesterol and glucose significantly improves HF mortality prediction accuracy compared to latest measures.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
24
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
37
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
137
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
130